Skip to main content
Publication date
2017 04 20
Authors
Ridker, PM Revkin, J Amarenco, P Brunell, R Curto, M Civeira, F Flather, M Glynn, RJ Gregoire, J Jukema, JW Karpov, Y Kastelein, JJP Koenig, W Lorenzatti, A Manga, P Masiukiewicz, U Miller, M Mosterd, A Murin, J Nicolau, JC Nissen, S Ponikowski, P Santos, RD Schwartz, PF Soran, H White, H Wright, RS Vrablik, M Yunis, C Shear, CL Tardif, JC
Group authors
SPIRE Cardiovascular Outcome Inve
Pubmed ID
28304242
Journal
The New England journal of medicine
Doctype
Article
KI Connection
Låg
Mesh SV
Antikroppar Behandlingssvikt Dubbelblindmetod Fetter Hjärt-kärlsjukdomar Hyperkolesterolemi Injektioner, subkutana Kolesterolsänkande medel Kvinnlig LDL-kolesterol Manlig Medelålders personer Monoklonala antikroppar, humaniserade Människa Riskfaktorer Uppföljningsstudier
Mesh EN
Antibodies Antibodies, Monoclonal, Humanized Anticholesteremic Agents Cardiovascular Diseases Cholesterol, LDL Double-Blind Method Follow-Up Studies Hypercholesterolemia Injections, Subcutaneous Lipids Proprotein Convertase 9 Risk Factors Treatment Failure
First date
2017-05-14T11:05:12.447Z